![](/wp-content/uploads/2019/08/az-onedrop-proventionbio-mannkind-announcement.png)
$599
Forxiga DECLARE EU Approval, BTD For Provention Bio’s Teplizumab (PRV-031), And MannKind/One Drop Collaboration
Today, three key news items were observed including the Forxiga DECLARE EU approval, Breakthrough Therapy Designation to Provention Bio’s Teplizumab (PRV-031) and a MannKind/ One Drop collaboration. Below, FENIX provides context and analysis for these announcements.